BBH

Featured

Biogen Boosts Biotech ETFs to More New Highs

By Todd ShriberMarch 20, 2015

Featured

ETFs for the Next Biotech Takeover Targets

By Todd ShriberMarch 10, 2015

Featured

A Biotech ETF Right for Oncology Mergers and Acquisitions

By Todd ShriberMarch 9, 2015

Featured

Healthcare ETFs up at Least 10% This Year

By Tom LydonFebruary 26, 2015

Featured

Healthcare ETFs Have More Room to Run

By Tom LydonFebruary 11, 2015

Featured

Gilead Could Goose Biotech ETFs

By Todd ShriberFebruary 4, 2015

Featured

‘Tis the Season for Biotech ETFs

By Todd ShriberJanuary 5, 2015

Featured

The Dominance of Health Care ETFs in One Chart

By Todd ShriberNovember 20, 2014

Featured

Biotech ETFs Prescribe New ETFs

By Todd ShriberOctober 23, 2014

Featured

Biotech ETFs Aren’t Waving the White Flag…Yet

By Tom LydonOctober 15, 2014

Featured

Biotech ETFs Look to Build on Hot August Returns

By Tom LydonSeptember 3, 2014

Featured

So Much for That Biotech ETF Bubble

By Todd ShriberAugust 20, 2014

Equity ETFs

Most Searched ETFs: Tactical Time

By Todd ShriberJune 28, 2014

Featured

Vertex Lifts These Biotech ETFs

By Todd ShriberJune 24, 2014

Featured

More Upside Possible for Biotech ETF

By Todd ShriberMay 6, 2014

Featured

Biotech ETFs in Bear Market, Plunge Below Key Trendlines

By Tom LydonApril 15, 2014

Featured

Investors Say Bye-Bye to Biotech ETFs

By Todd ShriberApril 8, 2014

Featured

ETF Performance Report: March & Q1

By Max ChenMarch 31, 2014